These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 227238)

  • 1. Choice of cell substrate for biological products.
    Beale AJ
    Adv Exp Med Biol; 1979; 118():83-97. PubMed ID: 227238
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell substrate for killed poliovaccine production.
    Beale AJ
    Dev Biol Stand; 1981; 47():19-23. PubMed ID: 6262147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results on the use of human diploid fibroblasts for inactivated polio virus vaccine production.
    Larsson B; Litwin J
    Dev Biol Stand; 1980; 46():241-7. PubMed ID: 6245000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Line cell saga - an argument in favor of production of biologics in cancer cells.
    Hilleman MR
    Adv Exp Med Biol; 1979; 118():47-58. PubMed ID: 227236
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on safety tests of inactivated poliomyelitis vaccines. IV. Comparative safety tests in rhesus monkeys and long-tailed monkeys (Cercopithecus aethiops)].
    Günther O; Hövel H; von Mettenheim A; Burde K; Heber L; Unterharnscheidt F
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):137-50. PubMed ID: 4296870
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of enhanced plaque formation by poliovirus in poxvirus-infected cells.
    Tsuchiya Y; Tagaya I
    J Gen Virol; 1972 Mar; 14(3):237-42. PubMed ID: 4336519
    [No Abstract]   [Full Text] [Related]  

  • 7. New trends in the preparation of cell substrates for the production of virus vaccines.
    van Wezel AL
    Prog Immunobiol Stand; 1971; 5():187-92. PubMed ID: 4349819
    [No Abstract]   [Full Text] [Related]  

  • 8. SV40 and human cancer.
    Hayflick L
    Science; 1997 Apr; 276(5311):337-8. PubMed ID: 9139350
    [No Abstract]   [Full Text] [Related]  

  • 9. Poliovirus type 3 isolation from infants with respiratory diseases.
    Sărăţeanu D; Popescu G; Botiş S; Baba C
    Rev Roum Virol (1972); 1973; 10(3):227-32. PubMed ID: 4359718
    [No Abstract]   [Full Text] [Related]  

  • 10. PER.C6(®) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine.
    Sanders BP; Edo-Matas D; Custers JH; Koldijk MH; Klaren V; Turk M; Luitjens A; Bakker WA; Uytdehaag F; Goudsmit J; Lewis JA; Schuitemaker H
    Vaccine; 2013 Jan; 31(5):850-6. PubMed ID: 23123018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on characteristics of poliovirus. II. Plaque-forming capacity of attenuated poliovirus strains in human and monkey kidney cell cultures.
    Böttiger M
    Arch Gesamte Virusforsch; 1966; 18(2):127-34. PubMed ID: 4293024
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the biological properties of vaccinal strains of type 3 poliomyelitis virus isolated from children in Sverdlovsk].
    Shchekochikhina EA; Dodonova NN; Dzagurov SG; Omel'chenko TN; Tsetlin EM
    Vopr Virusol; 1973; 18(4):484-9. PubMed ID: 4362265
    [No Abstract]   [Full Text] [Related]  

  • 13. A brief history of polio vaccines.
    Blume S; Geesink I
    Science; 2000 Jun; 288(5471):1593-4. PubMed ID: 10858138
    [No Abstract]   [Full Text] [Related]  

  • 14. The production of inactivated poliovaccine on serially cultivated kidney cells from captive-bred monkeys.
    van Wezel AL; van der Velden-de Groot CA; van Herwaarden JA
    Dev Biol Stand; 1980; 46():151-8. PubMed ID: 6244995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O; VON METTENHEIM ; HOEVEL H
    Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the reactivity of macrophages to enterovirus infections. 3. Reproduction of wild, attenuated and intermediate strains of Poliomyelitis virus in macrophage culture].
    Kańtoch M; Dobrowolska H
    Med Dosw Mikrobiol; 1968; 20(2):207-12. PubMed ID: 4299408
    [No Abstract]   [Full Text] [Related]  

  • 17. Poliomyelitis eradication: a continuing story.
    Robbins FC
    FASEB J; 1994 Jun; 8(9):665-6. PubMed ID: 8005394
    [No Abstract]   [Full Text] [Related]  

  • 18. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on safety tests of inactivated poliomyelitis vaccines. V. Pathomorphological changes in the CNS of rhesus monkeys (Macaca rhesus) and long-tailed monkeys (Cercopithecus aethiops) following intracerebral and intralumbar inoculation with inactivated poliovirus types I, II, and 3].
    Unterharnscheidt F; Günther O; Hövel H; Burde K; Heber L
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):150-66. PubMed ID: 4296871
    [No Abstract]   [Full Text] [Related]  

  • 20. [Test of the potency of trivalent oral polio vaccines: comparison of 2 methods of reading].
    Chocarro LB; Manau MV
    Rev Argent Microbiol; 1987; 19(2):65-9. PubMed ID: 2459727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.